How many clinical trials are there for Thromboembolic Events?

PlainTrial tracks 1 US clinical trials for Thromboembolic Events, of which 1 are currently recruiting.

Which interventions appear most often on Thromboembolic Events trial records?

Enoxaparin Sodium Injection 40 mg QD is the most-linked intervention name on Thromboembolic Events records (1 trial links), followed by Enoxaparin Sodium Injection 30 mg BID. Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Thromboembolic Events?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Thromboembolic Events: later-stage trial registry

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed Thromboembolic Events trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Thromboembolic Events: 1 US clinical trial tracked, 1 recruiting.

Thromboembolic Events is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Oregon Health and Science University, running 1 of these trials.

Enrollment posture brief

Registry condition thromboembolic-events

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near Thromboembolic Events

Thromboembolic Events lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Thromboembolic Events on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Thromboembolic Events is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING Phase 4 606 participants

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Oregon Health and Science University

NCT02342444

Phase Distribution

Phase	Trial count
Phase 4	1

Top Sponsors

Oregon Health and Science University 1 trials

Named interventions

Most-linked intervention names on Thromboembolic Events records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Enoxaparin Sodium Injection 40 mg QD Drug

1 trials

Enoxaparin Sodium Injection 30 mg BID Drug

1 trials

US sites by state

Facility locations filed on Thromboembolic Events trials. A trial with sites in several states counts in each.

Oregon 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Thromboembolic Events page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 Thromboembolic Events trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
Oregon Health and Science University sponsors the most Thromboembolic Events trials on record, review their full trial history before evaluating a specific study. See Oregon Health and Science University's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Thromboembolic Events condition card totals 1 registered trials; most-linked intervention Enoxaparin Sodium Injection 40 mg QD; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.